|
 |
| home > epc > summer 2002 > offering a global service to support clinical trial |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Speed, quality and continuity of service are essential when it comes to the analysis of samples taken in clinical trials. Pharmaceutical and biotechnology companies require sample turnaround within 24 hours because patients may require further testing or treatment based on laboratory results. In addition to analytical quality, logistics are critical to ensuring rapid shipment and results turnaround, and therefore the location of laboratories is fundamental.
For a Phase I/IIa study involving a limited number of sites, logistics tend not to be as complex as for a multi-site Phase IIb/III study, which are often conducted on a number of continents. Each country will have its own custom regulations and it is essential that a central laboratory understands them and knows the best ways to prevent shipment delays. For a successful Phase IIb/III trial, the location of laboratories is fundamental. For example, it is almost impossible to undertake a study in South Africa which requires rapid sample analysis if the central laboratory is located in Europe or North America.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Inaugural Conference on Pre-Filled Syringes
21-22 January 2009, Crowne Plaza Hotel - St James, London, UK
SMi present their Inaugural Conference on Pre-Filled Syringes 21st and 22nd January 2009 at the Crowne Plaza Hotel - St James, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Aegate Proves Authenticating Drugs at the Point of Dispensing Protects Consumers
More info >> |
|
 |
